A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Atavistik Bio, Inc
BeOne Medicines
Seagen Inc.
Seagen Inc.
Eli Lilly and Company
Tesaro, Inc.
Hoffmann-La Roche
Merck Sharp & Dohme LLC
Hoffmann-La Roche
Genmab
AstraZeneca
Imunon
Eisai Inc.
Arcus Biosciences, Inc.
USWM, LLC (dba US WorldMeds)
Qurient Co., Ltd.
AstraZeneca
AbbVie
AstraZeneca
EMD Serono
Poseida Therapeutics, Inc.
AstraZeneca
GlaxoSmithKline
Haihe Biopharma Co., Ltd.
AstraZeneca
Impact Therapeutics, Inc.
Amgen
AstraZeneca
AstraZeneca
AstraZeneca
Gilead Sciences
ImmunityBio, Inc.
Hoffmann-La Roche
Seagen Inc.
Merck Sharp & Dohme LLC
Novartis
Tesaro, Inc.
Takeda
AstraZeneca
EMD Serono
Varian, a Siemens Healthineers Company
Verastem, Inc.
AstraZeneca
Incyte Corporation
EMD Serono
NeoTX Therapeutics Ltd.
Medtronic - MITG
HiFiBiO Therapeutics
Akeso
BicycleTx Limited